A Dose-finding Study to Evaluate the Change in Weight After Treatment With LIK066 in Japanese Patients With Obesity
Status:
Completed
Trial end date:
2018-07-25
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the efficacy, tolerability and safety of LIK066 to
support dose selection for Phase 3 development in Japanese adults with obesity disease.